Skip to main content

Amlan International Becomes Full Operating Owner of Agromex, Strengthening Market Presence in Mexico

AgroMex, an Oil-Dri Corporation of America Company

AgroMex is part of Amlan International, an Oil-Dri Company.
AgroMex is part of Amlan International, an Oil-Dri Company.

CHICAGO, June 27, 2023 (GLOBE NEWSWIRE) — Amlan® International, the animal nutrition and health business of Oil-Dri® Corporation of America (NYSE: ODC), a global leader in mineral science for over 80 years, is pleased to announce the completion of its acquisition of the remaining non-controlling interest of Agromex Importaciones, S.A. de C.V. on May 12, 2023. Amlan now holds 100% ownership of its subsidiary in Mexico, further solidifying its position in the Mexican market.

Oil-Dri initially acquired a majority share in Agromex Importaciones in 2018, establishing a presence in Mexico’s animal health industry. Building on this successful partnership, Amlan has taken this strategic step to instill confidence in their customers and leverage the full potential of Agromex to accelerate its growth in the region. This ownership structure reinforces Amlan’s commitment to providing the market with the highest standards of operational excellence as a reliable partner in animal production, offering proven products and superior technical service.

With this acquisition, Agromex will benefit from the leadership of a new Board of Directors consisting of industry experts and seasoned professionals. Dr. Wade Robey, President, Amlan International, and Vice President of Agriculture, Oil-Dri Corporation of America has been appointed as the Chairman of the Board. Dr. Robin Jarquin, Regional Director Latin America, will oversee the operations of Agromex, ensuring a seamless transition and continued success of the subsidiary.

“The poultry industry in Mexico is significant with approximately 46 million broilers processed weekly. Although a substantial portion of the poultry industry in Mexico already uses mycotoxin binders, tremendous growth is still possible. With rising feed prices, at times uncertain grain quality, and the consumers’ desire to remove antibiotics when possible, the products in our portfolio can deliver real value to producers. With this recent change of Agromex’s ownership and sales strategy, we expect to grow Amlan’s business in Mexico rapidly over the next three years,” said Dr. Robin Jarquin.

Agromex will maintain its core focus on selling Amlan’s portfolio of innovative feed additives including Varium® and NeoPrime®, our patented formulations designed to promote efficiency for poultry and swine; Phylox®, a natural alternative to anticoccidial drugs and vaccines; Calibrin® -Z to defend against a broad spectrum of biotoxins; and Calibrin® -A to rapidly bind aflatoxin. By leveraging mineral technology, our products optimize intestinal health to help enhance animal performance, productivity, and overall well-being.

“We are excited about the prospects this acquisition brings and are eager to further strengthen the relationship with our customers in Mexico,” said Heath Wessels, Vice President of Sales, the Americas. The combined expertise and resources of Amlan, Oil-Dri and Agromex will contribute to the continued success and growth of our business in Mexico.

Product availability may vary by country. Associated claims do not constitute medical claims and may differ based on government requirements.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c3305a48-09e8-4fd2-9b24-fb3c6a91eacc

CONTACT: Media Contact
Reagan Culbertson
VP, Strategic Marketing
Press@amlan.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.